Drug Shortage Report for UROMITEXAN
| Report ID | 51103 |
| Drug Identification Number | 02371839 |
| Brand name | UROMITEXAN |
| Common or Proper name | Uromitexan |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | MESNA |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10mL |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2018-06-01 |
| Actual start date | 2018-06-01 |
| Estimated end date | 2018-06-21 |
| Actual end date | 2018-06-21 |
| Shortage status | Resolved |
| Updated date | 2018-06-22 |
| Company comments | Substitutes available: 2639B2019 (Uromitexan 4mL ampoule), 2639B2010 (Uromitexan 10mL ampoule) |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-06-22 | English | Compare |
| v5 | 2018-06-21 | French | Compare |
| v4 | 2018-06-21 | English | Compare |
| v3 | 2018-06-02 | English | Compare |
| v2 | 2018-06-01 | French | Compare |
| v1 | 2018-06-01 | English | Compare |
Showing 1 to 6 of 6